Since the vancomycin guideline update, institutional leaders have been faced with the challenge of implementing and monitoring AUC-guided dosing.
Matthew Girgis, PHARMD, BCIDP
Advertisement
Girgis is an infectious diseases and antimicrobial stewardship pharmacy specialist at Trillium Health Partners in Ontario, Canada. In addition to coleading the antimicrobial stewardship program, he spends his time talking hockey and recommending steakhouses to anyone who will listen.
Articles by Matthew Girgis, PHARMD, BCIDP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Is 4 Weeks of Glecaprevir/Pibrentasvir Sufficient to Treat Early Hepatitis C Infection?
2
Antibiotic Shows Promise in Treating Gram-Positive Pneumonia, Including in High-Risk Patients
3
As NDM-CRE Infections Rise Significantly, Diagnostic Access Emerges as Weak Link
4
Vaccines as a Secondary Strategy in the Fight Against Antimicrobial Resistance
5
